Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit - manually
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit - manually
Asym./Biol. Unit - manually  (Jmol Viewer)
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF PLGF IN COMPLEX WITH DOMAIN 2 OF VEGFR1
 
Authors :  H. W. Christinger, G. Fuh, A. M. De Vos, C. Wiesmann
Date :  12 Dec 03  (Deposition) - 20 Jan 04  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.45
Chains :  Asym./Biol. Unit :  V,W,X,Y
Keywords :  Plgf, Vegf Family, Cystine Knot, Growth Factor, Ligand-Receptor Complex, Specificity, Hormone-Growth Factor-Receptor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  H. W. Christinger, G. Fuh, A. M. De Vos, C. Wiesmann
The Crystal Structure Of Placental Growth Factor In Complex With Domain 2 Of Vascular Endothelial Growth Factor Receptor-1.
J. Biol. Chem. V. 279 10382 2004
PubMed-ID: 14684734  |  Reference-DOI: 10.1074/JBC.M313237200
(for further references see the PDB file header)

(-) Compounds

Molecule 1 - PLACENTA GROWTH FACTOR (PLGF)
    ChainsV, W
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    FragmentRECEPTOR BINDING DOMAIN
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
 
Molecule 2 - FLT1 PROTEIN
    ChainsX, Y
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System Taxid562
    FragmentDOMAIN-2
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606

 Structural Features

(-) Chains, Units

  1234
Asymmetric/Biological Unit VWXY

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric/Biological Unit (1, 1)
No.NameCountTypeFull Name
1B3P1Ligand/Ion2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREGLN V:87 , TYR V:99 , GLU V:101 , GLN W:87 , TYR W:99 , GLU W:101 , HOH W:323 , GLU X:141 , GLU Y:141BINDING SITE FOR RESIDUE B3P W 301

(-) SS Bonds  (10, 10)

Asymmetric/Biological Unit
No.Residues
1V:34 -V:76
2V:59 -W:68
3V:65 -V:110
4V:68 -W:59
5V:69 -V:112
6W:34 -W:76
7W:65 -W:110
8W:69 -W:112
9X:158 -X:207
10Y:158 -Y:207

(-) Cis Peptide Bonds  (4, 4)

Asymmetric/Biological Unit
No.Residues
1Ser V:56 -Pro V:57
2Ser W:56 -Pro W:57
3Phe X:172 -Pro X:173
4Phe Y:172 -Pro Y:173

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 2)

Asymmetric/Biological Unit (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_042046E144KVGFR1_HUMANPolymorphism55974987X/YE144K

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 3)

Asymmetric/Biological Unit (2, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PDGF_2PS50278 Platelet-derived growth factor (PDGF) family profile.PLGF_HUMAN39-131  1W:21-113
2PDGF_1PS00249 Platelet-derived growth factor (PDGF) family signature.PLGF_HUMAN75-87
 
  2V:57-69
W:57-69

(-) Exons   (2, 4)

Asymmetric/Biological Unit (2, 4)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000002823971ENSE00001249591chr13:29069232-29068917316VGFR1_HUMAN1-22220--
1.2ENST000002823972ENSE00000938500chr13:29041754-2904165897VGFR1_HUMAN22-54330--
1.3ENST000002823973ENSE00000938501chr13:29041266-29041040227VGFR1_HUMAN54-130770--
1.4ENST000002823974ENSE00000906630chr13:29012482-29012358125VGFR1_HUMAN130-171422X:133-171
Y:133-171
39
39
1.5ENST000002823975ENSE00000906629chr13:29008357-29008195163VGFR1_HUMAN172-226552X:172-224
Y:172-224
53
53
1.6ENST000002823976ENSE00000906628chr13:29008092-29007956137VGFR1_HUMAN226-271460--
1.7ENST000002823977ENSE00000906627chr13:29005447-29005273175VGFR1_HUMAN272-330590--
1.8ENST000002823978ENSE00000906626chr13:29004304-29004187118VGFR1_HUMAN330-369400--
1.9ENST000002823979ENSE00000906625chr13:29002058-29001889170VGFR1_HUMAN369-426580--
1.10ENST0000028239710ENSE00000906624chr13:29001455-29001296160VGFR1_HUMAN426-479540--
1.11ENST0000028239711ENSE00000679737chr13:28980031-28979917115VGFR1_HUMAN479-517390--
1.12ENST0000028239712ENSE00000679735chr13:28971205-28971097109VGFR1_HUMAN518-554370--
1.13ENST0000028239713ENSE00001005702chr13:28964241-28963933309VGFR1_HUMAN554-6571040--
1.14ENST0000028239714ENSE00001005684chr13:28959168-28959022147VGFR1_HUMAN657-706500--
1.15ENST0000028239715ENSE00001005678chr13:28931822-28931691132VGFR1_HUMAN706-750450--
1.16ENST0000028239716ENSE00001005688chr13:28919688-28919582107VGFR1_HUMAN750-785360--
1.17ENST0000028239717ENSE00000679727chr13:28913437-28913305133VGFR1_HUMAN786-830450--
1.18ENST0000028239718ENSE00001005682chr13:28908266-28908162105VGFR1_HUMAN830-865360--
1.19ENST0000028239719ENSE00000679725chr13:28903865-28903752114VGFR1_HUMAN865-903390--
1.20ENST0000028239720ENSE00001005685chr13:28901687-2890159989VGFR1_HUMAN903-932300--
1.21ENST0000028239721ENSE00000679723chr13:28897083-28896927157VGFR1_HUMAN933-985530--
1.22ENST0000028239722ENSE00000679722chr13:28896496-2889639998VGFR1_HUMAN985-1017330--
1.23ENST0000028239723ENSE00001761843chr13:28895722-28895600123VGFR1_HUMAN1018-1058410--
1.24ENST0000028239724ENSE00000679720chr13:28893671-28893560112VGFR1_HUMAN1059-1096380--
1.25ENST0000028239725ENSE00001005671chr13:28891734-28891635100VGFR1_HUMAN1096-1129340--
1.26ENST0000028239726ENSE00001005693chr13:28886235-28886130106VGFR1_HUMAN1129-1164360--
1.27ENST0000028239727ENSE00000679717chr13:28885869-28885727143VGFR1_HUMAN1165-1212480--
1.28ENST0000028239728ENSE00001005655chr13:28883064-2888298085VGFR1_HUMAN1212-1240290--
1.29ENST0000028239729ENSE00000679715chr13:28880909-2888081595VGFR1_HUMAN1241-1272320--
1.30ENST0000028239730ENSE00001157319chr13:28877505-288744893017VGFR1_HUMAN1272-1338670--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain V from PDB  Type:PROTEIN  Length:94
 aligned with PLGF_HUMAN | P49763 from UniProtKB/Swiss-Prot  Length:221

    Alignment length:122
                                    49        59        69        79        89        99       109       119       129       139       149       159  
           PLGF_HUMAN    40 VVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECRHSPGRQSPDMPGDFRADAPSFLPPRRSLPM 161
               SCOP domains d1rv6v_ V: Placenta growth factor-1, PLGF-1                                                                                SCOP domains
               CATH domains 1rv6V00 V:22-115 Cystine-knot cytokines                                                                                    CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ..hhhhhhhhhh.eeeeeeeehhhhh......eee..eeeeeeee.......eeeeeeeeeeeeeeeeee......eeeeeeeeeeeeeeee----------------------------e. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) PDGF_2  PDB: - UniProt: 39-131                                                              ------------------------------ PROSITE (1)
                PROSITE (2) -----------------------------------PDGF_1       -------------------------------------------------------------------------- PROSITE (2)
                 Transcript -------------------------------------------------------------------------------------------------------------------------- Transcript
                 1rv6 V  22 VVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECR----------------------------PL 115
                                    31        41        51        61        71        81        91       101       111 |       -         -         -| 
                                                                                                                     113                          114 

Chain W from PDB  Type:PROTEIN  Length:95
 aligned with PLGF_HUMAN | P49763 from UniProtKB/Swiss-Prot  Length:221

    Alignment length:123
                                    48        58        68        78        88        98       108       118       128       138       148       158   
           PLGF_HUMAN    39 EVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECRHSPGRQSPDMPGDFRADAPSFLPPRRSLPM 161
               SCOP domains d1rv6w_ W: Placenta growth factor-1, PLGF-1                                                                                 SCOP domains
               CATH domains 1rv6W00 W:21-115 Cystine-knot cytokines                                                                                     CATH domains
           Pfam domains (1) -------------PDGF-1rv6W01 W:34-112                                                          ------------------------------- Pfam domains (1)
           Pfam domains (2) -------------PDGF-1rv6W02 W:34-112                                                          ------------------------------- Pfam domains (2)
         Sec.struct. author ...hhhhhhhhhh.eeeeeeeehhhhhhhhh..eee..eeeeeeee.......eeeeeeeeeeeeeeeeee......eeeeeeeeeeeeeeee----------------------------e. Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) PDGF_2  PDB: W:21-113 UniProt: 39-131                                                        ------------------------------ PROSITE (1)
                PROSITE (2) ------------------------------------PDGF_1       -------------------------------------------------------------------------- PROSITE (2)
                 Transcript --------------------------------------------------------------------------------------------------------------------------- Transcript
                 1rv6 W  21 EVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECR----------------------------PL 115
                                    30        40        50        60        70        80        90       100       110  |      -         -         - | 
                                                                                                                      113                          114 

Chain X from PDB  Type:PROTEIN  Length:92
 aligned with VGFR1_HUMAN | P17948 from UniProtKB/Swiss-Prot  Length:1338

    Alignment length:92
                                   142       152       162       172       182       192       202       212       222  
          VGFR1_HUMAN   133 RPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHR 224
               SCOP domains d1rv6x_ X: Second domain of the Flt-1 receptor                                               SCOP domains
               CATH domains 1rv6X00 X:133-224 Immunoglobulins                                                            CATH domains
               Pfam domains -------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...........eeee......eee...........eeee...eee......eeee...eeee...hhhhheeeeeeeee..eeeeeeeeee. Sec.struct. author
                 SAPs(SNPs) -----------K-------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4  PDB: X:133-171 [INCOMPLETE]  Exon 1.5  PDB: X:172-224 UniProt: 172-226             Transcript 1
                 1rv6 X 133 RPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHR 224
                                   142       152       162       172       182       192       202       212       222  

Chain Y from PDB  Type:PROTEIN  Length:92
 aligned with VGFR1_HUMAN | P17948 from UniProtKB/Swiss-Prot  Length:1338

    Alignment length:92
                                   142       152       162       172       182       192       202       212       222  
          VGFR1_HUMAN   133 RPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHR 224
               SCOP domains d1rv6y_ Y: Second domain of the Flt-1 receptor                                               SCOP domains
               CATH domains 1rv6Y00 Y:133-224 Immunoglobulins                                                            CATH domains
           Pfam domains (1) ----Ig_2-1rv6Y01 Y:137-224                                                                   Pfam domains (1)
           Pfam domains (2) ----Ig_2-1rv6Y02 Y:137-224                                                                   Pfam domains (2)
         Sec.struct. author ...........eeee......eee...........eeee...eee......eeee...eeee...hhhhh.eeeeeee....eeeeeeeee. Sec.struct. author
                 SAPs(SNPs) -----------K-------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------- PROSITE
               Transcript 1 Exon 1.4  PDB: Y:133-171 [INCOMPLETE]  Exon 1.5  PDB: Y:172-224 UniProt: 172-226             Transcript 1
                 1rv6 Y 133 RPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHR 224
                                   142       152       162       172       182       192       202       212       222  

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 4)

Asymmetric/Biological Unit

(-) CATH Domains  (2, 4)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (2, 4)

Asymmetric/Biological Unit
(-)
Family: PDGF (19)
(-)
Clan: Ig (577)
(-)
Family: Ig_2 (52)
2aIg_2-1rv6Y01Y:137-224
2bIg_2-1rv6Y02Y:137-224

(-) Gene Ontology  (69, 80)

Asymmetric/Biological Unit(hide GO term definitions)
Chain V,W   (PLGF_HUMAN | P49763)
molecular function
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0008201    heparin binding    Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0046982    protein heterodimerization activity    Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0031100    animal organ regeneration    The regrowth of a lost or destroyed animal organ.
    GO:0001658    branching involved in ureteric bud morphogenesis    The process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0007267    cell-cell signaling    Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
    GO:0032870    cellular response to hormone stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
    GO:0007565    female pregnancy    The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0051781    positive regulation of cell division    Any process that activates or increases the frequency, rate or extent of cell division.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0001938    positive regulation of endothelial cell proliferation    Any process that activates or increases the rate or extent of endothelial cell proliferation.
    GO:0060688    regulation of morphogenesis of a branching structure    Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0001666    response to hypoxia    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0002040    sprouting angiogenesis    The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
    GO:0048010    vascular endothelial growth factor receptor signaling pathway    Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

Chain X,Y   (VGFR1_HUMAN | P17948)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0036326    VEGF-A-activated receptor activity    Combining with vascular endothelial growth factor A (VEGF-A) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0036327    VEGF-B-activated receptor activity    Combining with vascular endothelial growth factor B (VEGF-B) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0019838    growth factor binding    Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0036332    placental growth factor-activated receptor activity    Combining with placental growth factor (PlGF) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0005021    vascular endothelial growth factor-activated receptor activity    Combining with a vascular endothelial growth factor (VEGF) and transmitting the signal across the plasma membrane to initiate a change in cell activity.
biological process
    GO:0000186    activation of MAPKK activity    The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
    GO:0001525    angiogenesis    Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
    GO:0048514    blood vessel morphogenesis    The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
    GO:0030154    cell differentiation    The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
    GO:0016477    cell migration    The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
    GO:0035924    cellular response to vascular endothelial growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.
    GO:0006935    chemotaxis    The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
    GO:0048598    embryonic morphogenesis    The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
    GO:0030522    intracellular receptor signaling pathway    Any series of molecular signals initiated by a ligand binding to an receptor located within a cell.
    GO:0002548    monocyte chemotaxis    The movement of a monocyte in response to an external stimulus.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0045766    positive regulation of angiogenesis    Any process that activates or increases angiogenesis.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0043552    positive regulation of phosphatidylinositol 3-kinase activity    Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0010863    positive regulation of phospholipase C activity    Any process that increases the rate of phospholipase C activity.
    GO:0048661    positive regulation of smooth muscle cell proliferation    Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
    GO:0030949    positive regulation of vascular endothelial growth factor receptor signaling pathway    Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:0006940    regulation of smooth muscle contraction    Any process that modulates the frequency, rate or extent of smooth muscle contraction.
    GO:0001666    response to hypoxia    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0048010    vascular endothelial growth factor receptor signaling pathway    Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0036323    vascular endothelial growth factor receptor-1 signaling pathway    Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor-1 (VEGFR-1) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0038084    vascular endothelial growth factor signaling pathway    A series of molecular signals initiated by the binding of a vascular endothelial growth factor (VEGF) to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    B3P  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Phe X:172 - Pro X:173   [ RasMol ]  
    Phe Y:172 - Pro Y:173   [ RasMol ]  
    Ser V:56 - Pro V:57   [ RasMol ]  
    Ser W:56 - Pro W:57   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1rv6
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  PLGF_HUMAN | P49763
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  VGFR1_HUMAN | P17948
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  0118
    Age Related InformationGenAge
  0171
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  PLGF_HUMAN | P49763
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  VGFR1_HUMAN | P17948
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        PLGF_HUMAN | P497631fzv
        VGFR1_HUMAN | P179481flt 1qsv 1qsz 1qty 2xac 3hng 4ckv 4cl7 5abd 5ex3 5t89

(-) Related Entries Specified in the PDB File

(no "Related Entries Specified in the PDB File" available for 1RV6)